Nobel Prize in Physiology and Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Rice for discovering the virus that causes hepatitis C…

THE three scientists who made seminal contributions to the discovery of a novel virus, the hepatitis C virus (HCV), are joint recipients of this years Nobel Prize for Physiology or Medicine. Before their path-breaking work, the known agents that caused hepatitis (liver inflammation) were the hepatitis A virus (HAV) and the hepatitis B virus (HBV). HAV is responsible for hepatitis transmitted through contaminated food and water (infectious or epidemic hepatitis), and HBV is responsible for hepatitis transmitted through blood and bodily fluids (serum hepatitis).

HCV is the second causative agent of blood-borne hepatitis, a major health problem that causes cirrhosis and liver cancer in several thousands of people around the world.

While the discovery of HAV and HBV marked crucial advances in controlling the burden of hepatitis around the world until about the 1970s, the majority of blood-borne hepatitis cases still remained unexplained, particularly post-blood transfusion hepatitis. During blood transfusions, it was observed that even when donor blood that tested positive for HBV was carefully excluded a lot of transfusion recipients still ended up developing chronic hepatitis with serious long-term effects.

In a statement following the announcement of the award, the Nobel Committee said: The discovery of Hepatitis C virus revealed the cause of the remaining cases of chronic hepatitis and made possible blood tests and new medicines that have saved millions of lives. This virus, observed Thomas Perlmann, the secretary of the Nobel Committee for Physiology or Medicine, in a brief post-announcement interview, has been a plague affecting millions of peopleand still is, unfortunately. Its hard to find something that is of such benefit to mankind as what we are awarding this year.

According to the 2015 Global Hepatitis Report of the World Health Organisation (WHO), the different types of viral hepatitis contribute substantially to the global burden of hepatic diseases: in the year of the report, HAV infection caused 114 million cases of acute hepatitis, while 257 million people lived with chronic HBV infection and 72 million with chronic HCV infection. Because of the chronic infections that HBV and HCV lead to, they are major causes of morbidity and mortality with 1.34 million deaths reported in 2015, a 63 per cent increase from 1990, mainly because of HCV infection. This is comparable to the deaths tuberculosis caused (1.5 million reported in 2018) and higher than the deaths due to AIDS (6,90,000 reported in 2019).

The joint winners of the Nobel Prize are 85-year-old Harvey J. Alter, chief of the infectious diseases section and Associate Director of research at the Department of Transfusion Medicine at the National Institutes of Health (NIH), Maryland, United States; 71-year-old Michael Houghton, a professor of virology at the University of Alberta in Canada; and 68-year-old Charles M. Rice of Rockefeller University in New York. They were responsible respectively for three crucial steps involved in identifying and establishing that HCV was the causative virus for what was being described as non-A, non-B hepatitis (NANBH) (see figure).

Even though alcohol abuse, environmental toxins and autoimmune conditions can cause hepatitis, the major burden of this disease is owing to viral infections. In the 1940s, it was already known that there were two types of infectious hepatitis, A and B. The first has a short incubation period, has little long-term impact, is self-limiting, and infection results in life-long immunity. It is now known that the RNA viruses HAV and HEV cause hepatitis A, the latter having been identified only in the 1980s. Hepatitis B leads to a chronic condition in a high proportion of the patients and comes with a high risk of developing liver cancer or cirrhosis in the long term. It is now known that this long-incubation serum hepatitis is caused by the DNA virus HBV. This infection is insidious as otherwise healthy individuals can be silently infected for many years (during which period they can transmit the disease) before serious complications arise. But there is also a slight clinical variant of this disease, the discovery of whose causative agent is the story of this years Nobel Prize winners.

In the 1960s, Baruch Blumberg identified HBV, an important discovery that led to the development of diagnostic kits and an effective vaccine against it. For his discovery of HBV and the first-generation HBV vaccine, Baruch was awarded the 1976 Nobel Prize in Physiology or Medicine. As a young doctor and researcher, Alter had worked with Blumberg and made important contributions to the identification of the so-called Australia antigen (Au-antigen) in 1967, which, in fact, led to the discovery of HBV. Working as a clinical scientist at the NIHs large blood bank in the 1970s, Alter was studying the occurrence of hepatitis in post-blood transfusion patients. At that time, it was noticed that the exclusion (by serological tests) of HBV-antibody positive blood donors brought down the post-transfusion hepatitis cases only by 20 per cent; the remaining 80 per cent of the cases could not be explained and seemed unrelated to HBV infection. Blood tests showed that these cases were not caused by HAV either.

This NANBH differed from hepatitis B in its clinical manifestations: it had a short incubation period and much milder symptoms during the acute phase. While it resembled HBV in its modes of transmission, it led to chronic infection more frequently. In the late 1970s, after persistent efforts, Alter and colleagues developed a primate model of the infection. They showed that the blood from patients with acute or chronic NANBH could transmit the disease to chimpanzees, the only non-human species susceptible to the infection. Alter also demonstrated that the unknown infectious agent had the characteristics of a virus. His methodological investigations confirmed the existence of a distinct clinical form of post-transfusion hepatitis transmitted by an unknown virus.

Its a good story, Alter said in his post-announcement interview to the Nobel Committee, for a kind of non-directed research, where we have a hypothesis, but you have no idea where its going to go, just looking to see what caused post-transfusion Hepatitis, and initiated a very, very, very long study that involved many people. And that was all done at NIH, and probably could not have been done anywhere else because it took so long to come up with something you didnt really expect to find. But it was decades, and a lot of people, Bob Purcell and particularly Paul Holland and Paul Schmidt, who were in the blood bank with me the message that I think is important is that you dont always know where youre going. Nowadays research is so directed, and so has to come up with a drug fast, but at NIH they allowed me to just go my way.

But scientists found identification of this new virus frustratingly difficult. All the well-known methods for detecting a virus failed. It eluded isolation for over a decade. Houghton, who was working at the pharmaceutical company Chiron Corporation, took up the challenge in 1982, but the efforts of his team too proved unsuccessful. In 2018, Houghton told The Lancet that the quest to identify NANBH had driven his team to despair. For years, everything we attempted failed, he said. We tried all the methods that had proven successful for other infectious agents. We could not find an antigen in the blood, we were not able to grow the virus in cell culture, and if you looked in an electron microscope, you could not see it.

Moving to Alberta, Houghton then followed an unorthodox molecular approach. He and his co-workers Qui-Lim Choo and George Kuo created a library of DNA fragments from the nucleic acids found in the blood of an infected chimpanzee and screened it for viral DNA segments. Most of the fragments were found to be from the chimpanzees own genome, but the researchers kept at it as it was logical to expect that some of the fragments would be of the virus. The team then decided to try a clever and novel screening approach. Since antibodies to the virus would be present in the blood taken from NANBH patients, they used patients sera as the detecting tool to identify the DNA fragments encoding for the viral proteins.

The researchers transferred the library of DNA fragments of the infected chimpanzee to bacteria using a highly efficient bacteriophage system as the vehicle. (Bacteriophage is a kind of virus that infects bacteria.) The expression of viral antigens in the system was identified using sera from NANBH patients. Over two years, they screened millions of cloned bacterial colonies and finally found one colony that contained neither human nor chimpanzee DNA sequences. The years of painstaking work finally paid off: the team had found what it was looking for. Houghton and colleagues then showed that the clone was derived from a novel RNA virus belonging to the Flavivirus family, and the pathogen finally got its name, HCV. The clinching evidence came from the molecular complexes that antibodies of chronic NANBH patients formed with the proteins that the viral DNA fragments from the infected chimpanzee encoded for. The results of the experiments that led to the discovery were published in 1989.

At the time of trying to discover Hep C in the 80s, Houghton said in his post-announcement interview to the Nobel Committee, it was a difficult task. We didnt have the tools available then that we do now of course. So, it was a lot of effort actually, a lot of brute force, and just trying to use and apply all the methods available then. And we must have tried 30 different approaches at least over seven or eight years, and eventually we got one clone, after screening probably hundreds of millions of clones. So, yes, I work with some great people, without whom I would not have had this success. And we worked very hard, and so a lot of hard work and persistence was part of our success story, for sure. Following the identification of the virus, Houghton and associates quickly developed an assay to detect HCV-specific antibodies in the blood of a donor who had transmitted the disease to 10 recipients and in the blood of NANBH patients from Italy, Japan and the United States, thus establishing a relationship between HCV infection and NANBH.

[Q]uickly after we discovered the virus, we developed a blood test, [which] was the most urgent need to protect the blood supply. And then of course the two big challenges were trying to find therapeutics for the virus, and that took a long time. It took the whole field and the pharmaceutical industry working for more than 20 years. But eventually, weve got these wonderful drugs now that can cure nearly everybody quite quickly and safely. But it is an epidemic, global epidemic. It is a pandemic. HCV today kills around 400,000 people every year, Houghton said. But there was still a missing piece in the puzzle. What Houghton and colleagues showed was not really definitive proof of a causal connection between HCV infection and the chronic hepatitis disease. What they had demonstrated was, in some sense, only a correlation between the two. The transmission of the disease by transfer of infectious blood did not exclude the involvement of other cofactors in the causation of the disease. It remained to be proved that the virus alone was causing the disease. That required isolation of a virus capable of causing all the clinical features of NANBH, including chronic liver damage and persistence of the infectious agent in the blood of the patient. Basically, it had to be shown that the cloned virus was capable of replicating in the host and causing the disease. Although the virus now had a name, it remained elusive. No one had demonstrated that it replicated in the host. It was left to the third laureate to do that.

Rice, then a researcher at Washington University in St. Louis, Missouri, along with other groups working on RNA viruses, realised that in characterising the HCV genome a sequence of about 100 bases at one of its ends (the so-called 3 end) had been missed. He reasoned that this sequence could play an important role in viral replication. These small RNA viruses do not carry a lot of extra baggage; you have to make sure you have everything in the right place, he said while speaking to The Lancet after the award. Rice first constructed viral RNA genomes that had the end conserved region (the 3 end) intact and injected them into the liver of chimpanzees and looked for evidence of viral multiplication. But, unfortunately, he could not detect any newly produced virus in the chimpanzees blood. Rice was also aware that there could be significant copying errors in the replication of RNA viruses and had, indeed, noted that there were significant variations in the isolated virus samples. He surmised that some of these mutations could actually hinder viral replication. Through genetic engineering, Rice then built a set of consensus genomes of HCV that had the conserved 3 region and were also devoid of inactivating mutations. Injecting these genomes into the liver of chimpanzees produced evidence of replication, and productive infection was established.

We demonstrated that you could make a molecular clone of this virus that was infectious in chimpanzees, which was really the only validated system whereby HCV activity could be assessed, he told The Lancet. Thus, Rices work conclusively showed that HCV alone could cause persistent long-term hepatitis and stimulate a specific antibody response and all the clinical features of infection in humans.

To the post-announcement interviewer from Stockholm, Rice said: I feel as though Im just kind of a representative of the sort of molecular virologist community that contributed something to this fight against this disease. I think it was really just a joy actually to work in this community. I think people have been very generous with ideas and reagents. And that, together with the input of biotech and pharma, finally sort of came to the finish line in terms of developing these drugs that are so effective, that we have today. Now we still have some challenges in terms of making sure that everybody that needs them gets them and gets treated, but it is, I think, a success story for biomedical science and team science. And were seeing really an amazing follow-up example of that with the pandemic and the number of groups that have stepped up to the plate to work on SARS-CoV-2.

While the discovery of HCV paved the way for the development of effective drugs against the virus, it was not easy going. Although the full-length clones of the HCV genome Rice and colleagues created infected chimpanzees, they exhibited poor replication in cell lines, thus hindering in vitro studies of the virus life cycle and testing of potential antiviral drugs. Ralph Bartenschlager at the University of Heidelberg constructed the first sub-genomic clones of HCV that replicated efficiently in (infected) hepatoma (human liver cancer) cell lines.

The second obstacle was the absence of small animal models. Because the virus infected only humans and chimpanzees, the precise assessment of the pathological and immunological characteristics of the disease and clinical testing of potential drugs were not possible. This was overcome by creating genetically engineered knockout mice models. The availability of in vitro virus replication platforms and small animal models for in vivo studies led to the development of effective direct-acting antiviral (DAA) drugs that revolutionised the therapeutics against HCV infection. Chronic HCV hepatitis is now, in most cases, curable and the damage caused to tissues is often reversible.

According to the Nobel Committees background note to the award-winning HCV work, short-term antiviral treatment cures more than 95 per cent of patients, including advanced cases who failed to respond to previous therapeutic regimens, and has already benefited millions of individuals worldwide. The remaining obstacles towards the eradication of viral hepatitis, the note says, are now mostly associated with the lack of broad screening campaignsaccording the WHO Global Hepatitis Report 2017, fewer than 20 per cent of people with HBV- or HCV-associated hepatitis have been adequately diagnosedand, as Rice has pointed out, the high cost of the most effective treatments, which limits their availability to patients who cannot afford them, particularly those in low- and middle-income countries.

Like in the case of HIV/AIDS, Indian pharma companies have an important role to play here by stepping in to produce generic DAA drugs and becoming a supplier to low- and middle-income countries of the Third World.

Excerpt from:
Nobel Prize in Physiology and Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Rice for discovering the virus that causes hepatitis C...

What will rising ocean temperatures mean for its inhabitants? – World Economic Forum

Laboratory experiments indicate that many marine creatures could theoretically tolerate temperatures far higher than what they encounter today. But these studies dont mean that marine animals can maintain their current ranges in warmer oceans, says Curtis Deutsch, a professor of oceanography at the University of Washington.

Temperature alone does not explain where in the ocean an animal can live, says Deutsch. You must consider oxygen: how much is present in the water, how well an organism can take up and utilize it, and how temperature affects these processes.

Species-specific characteristics, overall oxygen levels, and water temperature combine to determine which parts of the ocean are breathable for different ocean-dwelling creatures.

The findings in Nature also provide a warning about climate change: Since warmer waters will harbor less oxygen, some stretches of ocean that are breathable today for a given species may not be in the future.

IN RESPONSE TO WARMING, THEIR ACTIVITY LEVEL IS GOING TO BE RESTRICTED OR THEIR HABITAT IS GOING TO START SHRINKING. ITS NOT LIKE THEYRE GOING TO BE FINE AND JUST CARRY ON.

Organisms today are basically living right up to the warmest temperatures possible that will supply them with adequate oxygen for their activity levelso higher temperatures are going to immediately affect their ability to get enough oxygen, says Deutsch.

In response to warming, their activity level is going to be restricted or their habitat is going to start shrinking. Its not like theyre going to be fine and just carry on.

Oxygen levels and temperatures vary throughout ocean waters. Generally, water near the equator is warmer and contains less oxygen than the cooler waters near the poles. But moving from the surface ocean to deeper waters, both oxygen and temperature decrease together.

These principles create complex 3D patterns of oxygen and temperature levels across depths and latitudes. An organisms anatomy, physiology, and activity level determine its oxygen needs, how effectively it takes up and uses the available oxygen in its environment, and how temperature affects its oxygen demand.

Deutsch and coauthorsJustin Penn, a doctoral student in oceanography, and Brad Seibel, a professor at the University of South Floridawanted to understand if breathability was a limiting factor in determining the ranges of marine animals today.

They combined data on temperature and oxygen content across the oceans with published studies of the physiology, oxygen demand, and metabolism of 72 species from five different groups of marine animals: cold-blooded vertebrates, like fish, and their relatives; crustaceans; mollusks; segmented worms; and jellyfish and their relatives.

The team modeled which parts of the ocean are and arent habitable for each species. They showed that a species current range generally overlaps with the parts of the oceans predicted to be habitable for it.

Their model predicts that the northern shrimp, a crustacean, should be able to get enough oxygen in cool waters north of about 50 degrees north latitudeand that is generally the shrimps range today. The small-spotted catshark can inhabit temperate and cool waters at a variety of depths, but near the tropics only near-surface watersabove about 300 feetare breathable, which is also reflected in its current range.

The small-spotted catshark is one of the species that are affected.

Image: Hans Hillewaert

In many cases, species ranges are right up to the edge of breathability, which indicates that for marine animals the ability to get enough oxygen may be a major limiting factor in determining where they can live, Deutsch adds. Outside of that range, organisms run the risk of hypoxia, or not getting enough oxygen.

Temperature, oxygen, physiology

Temperature affects both how much oxygen that seawater can hold, and how much oxygen an animal needs to maintain the same level of activity. The already-tight overlap the researchers saw between breathability and current ranges indicate that long-term rises in temperature, as expected under climate change, will likely restrict the ranges of many marine animals.

This new study follows a 2015 study of four Atlantic Ocean species by Deutschs team, and builds on its findings by showing that diverse species in all ocean basins are generally inhabiting the maximum range they currently can.

In the future, Deutsch wants to include additional species, and further explore the relationships among temperature, oxygen, and physiology.

The researchers would also like to find historical examples of marine species shifting their range in response to water breathability, as the team showed earlier this year with the northern anchovy.

What we really want to find are more observations of marine species moving around in accordance with what wed expect with temperature conditions and oxygen availability, says Deutsch. That will give us firm examples of what to expect as temperature and oxygen conditions fluctuate, and shift permanently with climate change.

The Gordon and Betty Moore Foundation, the National Oceanic and Atmospheric Administration, and the National Science Foundation funded the work.

See original here:
What will rising ocean temperatures mean for its inhabitants? - World Economic Forum

UK study: Tattoos can impair sweating, lead to heat-related injuries – ABC 36 News – WTVQ

UK Physiology Professor Thad Wilson co-led the study done in collaboration with researchers from University of Texas Southwestern Medical Center, Southern Methodist University, and Alma College. The team studied volunteers with arm tattoos and measured the participants sweat rates and body temperatures on both the tattooed and non-tattooed areas of skin on the same arm.

Results showed that skin of the arm containing tattoos has reduced sweat rates compared to the adjacent skin without tattoos. Researchers conclude that damage to the sweat glands caused by tattooing could be the cause and this in turn may increase the risk of overheating.

This could be a long-term and even permanent problem, Wilson said. Just like with any procedure, whether clinical or cosmetic, a person needs to consider all the potential side effects. This sweating related side effect is not being provided to people getting tattoos.

Although small tattoos are less likely to interfere with overall body temperature regulation, decreased sweating in tattooed skin could impact heat dissipation especially when tattooing covers a higher percentage of body surface area, the researchers wrote.

The study is first-of-its-kind, says Wilson. Other studies have looked into the acute inflammatory responses to the inks used in tattooing, but the delayed and potentially longer-lasting effects of the tattooing process are less studied.

The research team previously identified that sweat glands in tattooed skin lose more salt and now plans to pursue more studies addressing various inks and procedures used, as well as in people with a higher percentage of skin covered in tattoos.

Now that weve characterized the problem, we need to understand the exact mechanisms of why it occurs. This could ultimately lead to recommendations that change industry practices to decrease the amount and magnitude of tattoo-related side effects.

The rest is here:
UK study: Tattoos can impair sweating, lead to heat-related injuries - ABC 36 News - WTVQ

B.C.’s Wendy Pethick named top Canadian sports scientist by Own the Podium – PrinceGeorgeMatters.com

Only the Tokyo Olympics were postponed, not the humidity. That still awaits.

Only the Tokyo Olympics were postponed, not the humidity. That still awaits.

Canadian athletes can thank Wendy Pethick if they acclimatize well to the 30-plus degree summer temperatures expected next year in Japan for the pandemic-delayed 2020 Plus One Olympics and Paralympics.

The manager of the Canadian Sport Centre-Pacifics performance lab, located at the Pacific Institute for Sport Excellence on the Camosun College Interurban campus, has been named Canadas sport scientist of the year for 2020 by Own the Podium.

The award, inaugurated in 2019, is in its second year. There were five nominees. Pethick, a physiologist, was honoured this week during the annual Own the Podium Sport Innovation Summit. The summit was conducted virtually this year. Own the Podium is the program created in 2004 with the goal of elevating more Canadian athletes to Olympic and Paralympic podiums. It is funded primarily by the federal government with additional money provided by the Canadian Olympic Committee, Canadian Olympic Foundation and Canadian Paralympic Committee.

Pethick is considered a world leader in the study of thermoregulation, the process by which the body retains its core internal temperature. In terms of the Summer Games, it basically involves keeping an athletes body temperature moderated in hot conditions. Pethick has a breadth of knowledge and teaching experience in physiology, exercise physiology and in measuring and evaluating in those areas. Her work is transferable beyond just sports and she has also been involved in projects with the RCMP, Canadian Coast Guard and B.C. Forestry Service.

Wendy is a real unsung hero of Canadian sport [study and preparation], said Andy Van Neutegem of Victoria, the director of performance sciences, research and innovation for Own the Podium.

Her work is very important with Tokyo coming up. She is a very deserving winner of this award.

Up to 75 of the Canadian athletes expected to compete next summer in the Tokyo Olympics and Paralympics are based on the Island, and Pethick has worked with most of them, with especially close ties to the rowers, triathletes and wheelchair rugby players.

The University of Victoria exercise physiology masters graduate is not a bad athlete herself. Pethick has placed in the top-10 in the womens 55-plus age group in the New York, Chicago and Berlin marathons.

See the article here:
B.C.'s Wendy Pethick named top Canadian sports scientist by Own the Podium - PrinceGeorgeMatters.com

Lizards in US Exhibit Rapid Adaptation to Colder Temperatures; Provide New Insights On Climate Change Resilience | The Weather Channel – Articles from…

Central American brown basilisks (Basiliscus vittatus) are among the members of a lizard community that converged on a lower temperature tolerance after a cold snap in Miami.

Some lizard species in the USAs tropical city of Miami, Florida, which previously could not withstand extremely cold weather, now seem to have shockingly developed tolerance against it, new research has found.

January 21, 2020, marked one of the coldest nights in south Florida. The temperatures dropped so low, that the lizards that were napping on the trees ended up getting stunned, lost their balance, and fell off on the streets.

Researchers utilised this opportunity to collect the scaled survivors of this cold night, as it provided them with a unique chance to understand how lizards are affected by extreme climate events. Post collection and examination of the lizards, however, the researchers were stunned tooand not by the cold this time around.

The researchers found that all the lizards they collected off the Miami streets could survive temperatures as cold as 42 degrees Fahrenheit (5.5C). This was a lot lower than their previous tolerance levels which biologist James Stroud and his team, from previous research, knew to be between 46 to 52 degrees Fahrenheit (7.7 to 11.1C).

"Prior to this, and for a different study, we had measured the lowest temperatures that six lizard species in south Florida could tolerate. We realised after the 2020 cold event that these data were now extremely valuablewe had the opportunity to re-measure the same lizard populations to observe if their physiological limits had changed; in other words, could these species now tolerate lower temperatures?" Stroud added.

Before the event of the cold night, the temperature tolerance of the lizards varied. For example, large lizards like brown basilisk showed low tolerance to low temperatures, whereas other species like the Puerto Rican crested anole were comparatively more tolerant. But after the event, it was seen that all the lizard species were capable of tolerating the same levels of low temperature.

This was a surprising and unexpected outcome, as the species differ in body size, physiology, and ecology, and yet have the same level of cold tolerance. Therefore, these research findings acted as proof that tropical, cold-blooded animals whose primary characteristic is their inability to withstand rapid changes in climatic conditions, can sometimes withstand extreme climatic conditions that go beyond their established physiological limitations.

The shift towards tolerating such low temperatures is very significant. However, the researchers were unsure if the reason behind this was indeed natural selectiona process that results in the adaptation of an organism to its environment by means of selectively reproducing changes in its genetic constitution. The rapid evolution of this tolerance among the lizards has raised several questions.

Jonathan Losos, director of the Living Earth Collaborative at Washington University, described these tropical lizards ability to withstand near-freezing temperatures as very surprising, while also adding that our future goal should be to understand how this tolerance was achieved.

One perspective is that the lizards that could not tolerate the cold weather simply died, while the ones which had the tolerance survived. This can be attributed to the natural selection of species. On the other hand, it could also be an example of physiological adaptation, known as acclimation, in which case the physiology of lizards may have changed when exposed to lower temperatures, which effectively developed their tolerance.

"It is widely thought that tropical and subtropical species are going to be especially vulnerable to changes in temperatureparticularly extreme spikes of heat or coldas tropical areas do not typically have strong seasons," Stroud said. Temperate creatures, on the other hand, are well adapted to both summer and winter extremes.

But now, these new findings are bound to play an important role in helping us better understand the effects of climate change on tropical and subtropical species. While there is no question that climate change is a huge threat to ecosystems and species all around the world, Stroud has insisted that studies like this help us to build a new perspective. The results give a glimmer of hope that maybe, just maybe, such tropical and subtropical species are capable of tolerating extreme climatic conditions after all.

The study was published in the journal Biology Letters earlier this week and can be accessed here.

**

For weather, science, and COVID-19 updates on the go, download The Weather Channel App (on Android and iOS store). It's free!

Visit link:
Lizards in US Exhibit Rapid Adaptation to Colder Temperatures; Provide New Insights On Climate Change Resilience | The Weather Channel - Articles from...

5 tips on how to prepare food that will improve your intimate physiology – IOL

By Lutho Pasiya Oct 27, 2020

Share this article:

People have looked for ways to improve their sexual experience for thousands of years, including trying to discover the best foods for sex.

We talk about aphrodisiac foods like oysters, pomegranates and chocolate because we believe they get us in the mood.

Licensed acupuncturist Christine DeLozier says that if you want to nourish great sex, shes afraid its not with pizza and booze.

Food for great sex helps our nerves fire strong, rapid signals to and from the genitals.

It also balances sex hormones and supports arteries in delivering blood. And just so you know, females need ample blood flow for sexual pleasure too, says DeLozier.

Below are five tips by DeLozier on how to prepare snacks and meals that will improve your intimate physiology.

Save the ding dongs for the bedroom

Lots of research shows that refined sugars, found in things like packaged cupcakes, disrupt sex hormones.

Instead, choose a handful of nuts or a piece of fruit as a snack.

The latest sex toy: cruciferous

Science shows that these vegetables are like The Rabbit, eagerly waiting to service our sex organs.

Their nutrients protect and repair damage to nerves to the genitals for increased pleasure. Try broccoli or cauliflower with a squirt of lime and fresh dill.

Pork belly on brioche

Many studies have shown that a high-fat diet slows nerve conduction and impairs blood flow to the genitals, which directly translates to less pleasure for males and females.

Include salad-tossing in your repertoire.

Leaves, like spinach and arugula, are great for sex.

Theyre high in minerals like zinc, which help normalise testosterone in males and females.

Their phytonutrients improve the elasticity of blood vessels, for optimal blood flow.

Fill your cakehole

Include potassium-rich foods like mango, banana, or yam every day.

Potassium luxuriates the delicate inner lining of penile and clitoral blood vessels, for better sex.

In fact, research has shown that after eating a high-potassium meal, nitric oxide increases, and arterial function is measurably improved within a couple of hours.

Read the original:
5 tips on how to prepare food that will improve your intimate physiology - IOL

Homeoprotein transduction in neurodevelopment and physiopathology – Science Advances

Abstract

Homeoproteins were originally identified for embryonic cellautonomous transcription activity, but they also have noncell-autonomous activity owing to transfer between cells. This Review discusses transfer mechanisms and focuses on some established functions, such as neurodevelopmental regulation of axon guidance, and postnatal critical periods of brain plasticity that affect sensory processing and cognition. Homeoproteins are present across all eukaryotes, and intercellular transfer occurs in plants and animals. Proposed functions have evolutionary relevance, such as morphogenetic activity and sexual exchange during the mating of unicellular eukaryotes, while others have physiopathological relevance, such as regulation of mood and cognition by influencing brain compartmentalization, connectivity, and plasticity. There are more than 250 known homeoproteins with conserved transfer domains, suggesting that this is a common mode of signal transduction but with many undiscovered functions.

Cell-cell recognition is the basis for the initiation and evolution of multicellularity. From this point of view, such recognition must convey positional information for controlling cell differentiation and organ formation according to position. Homeobox genes, which were first discovered through their role in position-dependent morphogenesis, are at the forefront in this process (1). Besides multicellularity, another important recognition process is mating type, and in some unicellular eukaryotes, such as yeast or unicellular green algae, mating type is encoded by homeobox genes (24). However, in either case, most homeoproteins encoded by the homeobox genes have been regarded as purely cell-autonomous transcription factors that regulate the expression of secreted morphogenetic signals acting through classical transduction mechanisms.

Noncell-autonomous activity of homeoproteins was serendipitously discovered during the course of experiments in which the 60amino acidlong DNA binding domain (the homeodomain) of Antennapedia was injected into cells. The homeodomain added to culture medium in control experiments was spontaneously internalized by live cells, with direct addressing to cytoplasm and nucleus (5). Building on this first observation, it was demonstrated soon after that several full-length homeoproteins can be transferred between cells [reviewed in (6)]. While we will describe below current knowledge of the internalization and secretion mechanisms, it must be emphasized that the homeodomain, which is a very highly conserved structure (1, 4, 79), is necessary and sufficient for transfer both in plants and in animals (1012). This is probably why almost all homeoproteins tested so far (~150) have demonstrated intercellular passage, both in vitro and in vivo (13).

Homeoprotein transfer would have remained an eccentric observation had efforts not been made to identify important physiological functions of this unexpected signaling mechanism. Complicating this goal is that the transfer motifs are within the homeodomain sequence, making it impossible to genetically disrupt transfer without modifying DNA binding and, thus, cell-autonomous activities (12). A strategy to circumvent this difficulty involves minigenes encoding secreted single-chain antibodies (scFvs) (14). The antibodies expressed and secreted in vivo block homeoproteins only in the extracellular space, thus leaving intact their cell-autonomous functions. This strategy was very useful in elucidating the direct noncell-autonomous functions of a limited number of homeoproteins across five animal species (summarized in Table 1).

n.d., not determined.

Migration and guidance are of special interest in the context of positional information. Any migrating entity, say a cell or a growth cone (here considered as a neuron leading edge), needs to know which direction to take, a choice dictated, in part, by the original position and the lineage of the cell body. Several models explaining directed migration have been proposed, primarily implicating the presence of attractive and repulsive cues either attached to the substratum or diffusing into the environment (15). In this context, only those few morphogens bound to carriers following secretion have distant targets; otherwise, they remain trapped within the extracellular matrix, particularly through specific binding to proteoglycans, and do not diffuse freely (1618).

One of the most popular examples of guidance is that of retinal axons onto the superior colliculus (SC; mammal) or optic tectum (lower vertebrates). The system is more complex than summarized below, with several Ephrin ligand and Eph receptor subtypes and redundancy, but the principle holds that the nasotemporal Eph-receptor gradient at the surface of the growth cones and the anteroposterior gradient of EphrinA at the surface of the tectum/SC provides a way to limit the advance of the temporal axons onto the posterior territory (1921).

Graded expression of Engrailed homeoprotein in the tectum/SC is established by the expression of several factors, including WNT1, FGF8, and PAX family members, at the hindbrain/midbrain boundary and is required for proper positioning of nasal and temporal retinal axons along the anteroposterior axis of the tectum/SC (22). The regulation of positioning was first attributed to the Ephrin/Eph interactions according to the graded expression of EphrinA5, which is under Engrailed cell-autonomous transcriptional control (2326). However, neutralizing Engrailed in the extracellular space leads temporal axons to invade the posterior tectum, in frog and chick (Fig. 1) (27). The proposed mechanism is that Engrailed once internalized by the growth cones regulates the translation of mitochondrial mRNAs and induces ATP (adenosine triphosphate) synthesis, secretion, and degradation into adenosine, which results in the activation of adenosine receptor 1 (28, 29). This activation sensitizes the growth cones to low Ephrin concentrations (27, 30) and strongly suggests that the actual in vivo levels of Ephrins, and possibly of other morphogens as well, are much lower than those used for in vitro experiments.

(A) Schematic representation of the retina-tectum projection. Retinal ganglion cell axons (in yellow) coming from nasal (N) and temporal (T) retina enter the tectum (in blue) at its anterior (A) level and travel toward its posterior regions (P). Engrailed 1/2 and EphrinA5 show graded (low anterior/high posterior) expression. In contrast with nasal growth cones that invade the entire tectum, the temporal growth cones are repelled from posterior regions. (B) Noncell-autonomous EN1/2 graded expression participates in axon guidance. EN1/2 secreted from the tectum (in blue) is maintained in the extracellular matrix at a concentration reflecting the expression gradient (no diffusion) and internalized by the incoming growth cones (in yellow). Internalized EN1/2 regulates translation of complex I mitochondrial mRNAs leading to ATP synthesis, secretion, and degradation into adenosine. Adenosine and Ephrin signaling pathways interact, inducing grow cone collapse when a combined concentration threshold of extracellular EN1/2 and EphrinA5 has been reached (2729). (C) EphrinA5 signaling is enhanced by EN1/2 presence. This very simple scheme illustrates how EN1/2 addition increases the sensitivity of the response to low EphrinA5 concentration. In the presence of EN1/2, the growth cone response takes place at much lower EphrinA5 concentrations, allowing for growth cones to orient themselves along a shallow morphogen gradient.

Figure 1 illustrates some key messages to retain from these experiments. First, extracellular graded Engrailed distribution reflects the intracellular distribution, which means that the protein does not diffuse after its secretion (27). This local retention is probably, in part, electrostatic because of the negatively charged environment of the cell surface but may also involve specific interactions with glycosaminoglycans (GAGs), as shown for VAX1 and OTX2 (3133). A second point is the importance of cosignaling between adenosine, EphrinA5, and Engrailed (29). Such cosignaling was also found between Engrailed and decapentaplegic (DPP) in the fly wing disk (34) and between PAX6 and netrin in the neural tube (35). A final point of interest is the importance of local translation. In the in vitro turning assay with frog retinal axons, EN2 binds the translation initiation factor eIF4E once internalized and regulates the initiation of translation (28). In this assay, the inhibition of translation but not that of transcription blocks guidance. This is key since the growth cone is rapidly distanced from the cell body, and local activity allows for the information to be treated locally. Beyond axon guidance, local translation regulated by EN2 internalization has been generalized to the maintenance of the synaptic structure (36) and may be of wider interest for the regulation of synaptic strength in adult neuronal networks (3739).

Critical periods of plasticity are windows of time in postnatal development during which a particular neural circuit can be shaped by a specific sensory input (experience) and after which the changes are normally very limited. Ocular dominance is a well-studied critical period that shapes primary visual cortex (V1) output according to the input levels from each eye (40). If the inputs are imbalanced, perhaps due to eye misalignment (strabismus) or congenital cataract, then amblyopia will ensue with impaired visual acuity that cannot be cured during adulthood (41). This disorder affects 2 to 5% of the human population but can be reversed in children if treated before heightened plasticity closes (by ~7 years of age). Critical periods exist for diverse processes of increasing complexity, including, for example, filial imprinting, sensory processing, motor skills, language, and emotional control, and they typically occur in cascade across different neural circuits (4244). The mechanisms involved seem to be repeated across these diverse brain regions, be they for the triggers of critical period onset, the manifestation of plasticity, or the closure and consolidation of circuitry.

Critical period onset is driven by the maturation of fast-spiking GABAergic (-aminobutyric acidreleasing) inhibitory neurons that express parvalbumin (PV), leading to a shift in excitatory/inhibitory circuit balance and to various molecular changes in the extracellular matrix permissive to plasticity (42). PV cell maturation requires appropriate stimulus coupled with specific molecular signals, including OTX2. This homeoprotein exhibits noncell-autonomous activity in V1, as its locus is completely silent throughout the postnatal cortex (45). It is expressed along the visual pathway, from the retina (in retinal pigmented epithelium, photoreceptor cells, and bipolar cells) to the dorsal lateral geniculate nucleus (in GABAergic interneurons) to the SC (in principal cells). It is also highly expressed in the choroid plexus, an epithelium within brain ventricles that produces cerebrospinal fluid. When OTX2 levels are reduced in either the retina or choroid plexus, OTX2 protein levels are concomitantly reduced in V1 PV cells, PV expression is negatively affected, and V1 plasticity can be altered (45, 46). However, given that such manipulations can induce confounding cell-autonomous effects in either the retina or choroid plexus, methods involving extracellular blocking peptides or antibodies were developed to selectively target noncell-autonomous functions (14, 31, 45). OTX2 transfer into V1 not only triggers ocular dominance critical period onset but also is implicated in closure and consolidation, with constant OTX2 transfer into PV cells maintaining a nonplastic state in the adult (14, 31, 46). This high sensitivity of PV cell maturation state to OTX2 levels evokes a two-threshold model of OTX2 accumulation in PV cells, whereby a first OTX2 concentration threshold initiates opening and a second one initiates closure (Fig. 2A) (6). For example, OTX2 protein infusion in V1 accelerates both critical period onset and closure (45), while a 20% reduction in OTX2 accumulation is sufficient to reopen ocular dominance plasticity in the adult mouse and cure experimental amblyopia (31, 46). This two-threshold hypothesis is supported by genetic mouse models that knock down Otx2 expression at the source or that sequester extracellular OTX2 protein in cerebrospinal fluid or around PV cells through conditional expression of a secreted single-chain OTX2 antibody (14).

(A) A two-threshold model explains how critical period onset and closure are accelerated or delayed by increasing or reducing OTX2 uptake, respectively. Cortical infusion of OTX2 protein accelerates onset and closure (45). Critical period is delayed in heterozygote Otx2+/ mice (45) and in Otx2+/AA mice (49), in which perturbed chondroitin sulfate proteoglycan (CSPG) recognition reduces OTX2(AA) specificity for PV cells. Onset is also delayed in PV::Cre;scFv-Otx2 mice (14), which conditionally express in PV cells a secreted scFv directed against OTX2 that sequesters extracellular OTX2 protein. (B) Multiple critical periods are regulated by OTX2, as shown by functional experiments with the Otx2+/AA mouse (49). P, postnatal day. (C) OTX2 in cerebrospinal fluid is captured specifically by CSPGs in the extracellular matrix surrounding PV cells (31, 46). Once internalized into the nucleus, OTX2 regulates the expression of Gadd45 gene family, which, in turn, alter epigenetic marks and plasticity gene expression (52). It cannot be excluded that OTX2 binds to receptors or that OTX2-CSPG interactions modify cell-surface protein, which subsequently activate signal transduction. CSF, cerebrospinal fluid; ECM, extracellular matrix. (D) Plasticity windows are sensitive to OTX2 levels and are inhibited by elevated and constant accumulation of OTX2 in PV cells during adulthood. Acute reduction of OTX2 in adult permits cortical plasticity (14, 31, 46). Gadd45 expression is induced during both plasticity paradigms despite OTX2 levels moving in opposite directions (52).

While the mechanism of transfer from the choroid plexus to cortex has yet to be revealed, likely involving dedicated carriers, it is clear that the specificity of OTX2 for PV cells is dependent on its interaction with GAGs. The GAG-binding motif in OTX2 favors binding to disulfated GAGs present in perineuronal nets (PNNs) that surround PV cells (31). PNNs are dense extracellular matrices composed of hyaluronic acid, link proteins, and chondroitin sulfate proteoglycans (CSPGs) that accumulate and condense around select neurons (47, 48). Along with myelination, PNNs are an important feature of critical period closure that limit PV cell synaptic physiology, buffer ions and reactive species, and interact with signaling molecules. A genetic point mutation in the GAG recognition motif of OTX2 that decreases affinity for disulfated CSPGs results in reduced transfer specificity into PV cells and results in mice with delayed critical period timing (49). This mouse model supports the hypothesis that critical period mechanisms are recapitulated across brain regions; not only is V1 plasticity timing affected but also primary auditory cortex (A1) and medial prefrontal cortex (mPFC) plasticity timing (Fig. 2B). Thus, OTX2 is continually secreted into cerebrospinal fluid and accumulates specifically in PV cells throughout the cortex when retained by their PNNs.

OTX2 transfer into PV cells initiates a feedback loop, as it activates the expression of the PNNs that promote its accumulation (50). Various PNN molecules, including CSPGs and matrix-modifying proteases, are activated by OTX2, possibly by direct regulation of translation or by downstream changes in transcription (49, 51). This tight coupling between OTX2 levels, PV cell maturation, and PNN expression suggests that OTX2 can regulate bistable PV cell states that oscillate between permissive and consolidated. OTX2 also targets epigenetic programs (Fig. 2C). At a concentration level between the two thresholds that is compatible with plasticity, OTX2 activates the expression of GADD45 family proteins (52), which are implicated in regulating DNA methylation. Both OTX2-dependent juvenile critical period onset and induced adult plasticity result in the up-regulation of Gadd45 and in changes of gross indicators of chromatin organization (Fig. 2D). Epigenetic programming affects critical period timing, and its deregulation is implicated in autism spectrum disorders (53).

Homeoproteins are not unique in their ability to exit or enter cells, as unconventional protein secretion pathways have been described for several fully mature cytosolic or nuclear proteins that lack canonical secretion signals (54). EN2 secretion shares steps with type I unconventional protein secretion, originally described for FGF2 (55) and HIV Tat proteins (56). This secretion occurs by direct translocation through the plasma membrane and requires interaction with phosphatidylinositol diphosphate (PIP2) at the inner membrane leaflet (Fig. 3). However, while FGF2 (57) and Tat (58) oligomerize to create pores for their secretion, EN2 does not oligomerize, suggesting that it uses a different translocation mechanism following PIP2 binding. Nuclear magnetic resonance studies reveal that negatively charged membrane mimetics induce conformational modifications of the homeodomain that promote its insertion directly into the membrane hydrophobic core (59). EN2 internalization also requires binding to PIP2 (60), suggesting that exit and entry use very similar membrane translocation mechanisms (Fig. 3). Given the high conservation of the homeodomain sequence, EN2 transfer mechanism, studied in cell culture assays, is hypothesized to be similar for most homeoproteins that traffic.

Homeoprotein secretion requires nucleocytoplasmic shuttling activity to drive it from nucleus to cytosol (1). It is then transferred to the plasma membrane (2), partly through interactions with cholesterol-enriched internal vesicles, where it directly associates with cholesterol/PIP2-enriched domains. Once in contact with the negatively charged bilayer, structural modifications of the homeodomain motif initiate homeoprotein translocation across the plasma membrane. On the extracellular side, homeoprotein extraction from the bilayer depends on its interaction with cell-surface GAGs, which can also modulate the extent of homeoprotein diffusion in the medium (3). A reverse translocation process, also requiring cholesterol and PIP2, allows for protein entry that leads to cytosolic delivery and accumulation into diverse intracellular organelles (4). Plasma membrane translocation of the homeoprotein is a bidirectional process that creates a homeoprotein gradient on either side of the membrane. Gradient in/out equilibrium is modulated by protein concentration and by the physiological state of the cell.

Homeoproteins do not have classic secretion signals and traffic through the nucleus before secretion. For example, secretion is prevented if EN2 is retained in the nucleus by deleting its nuclear export sequence (61, 62). Plant KN1 homeoprotein is competent for transfer between plant cells in vivo through plasmodesmata (10, 63) and shows a similar requirement for nuclear import (10). KN1 homeodomain also transfers between mammalian cells, and deleting the nuclear localization sequence abolishes secretion (11). From an evolutionary perspective, the animal/plant comparisons suggest that the passage of KN1 through plasmodesmata involves similar mechanisms operating in animals. However, the nuclear factors and cytosolic transport mechanism for homeoprotein secretion remain unknown. One hypothesis is that they use intracellular vesicular flow to reach the plasma membrane, given that EN2 strongly interacts with cholesterol and negatively charged phospholipids and associates with caveolae-like vesicles (64).

Extracellular homeoproteins bind the plasma membrane before entering cells. Similar to all DNA-binding proteins, homeoproteins are prone to electrostatic interactions with nucleic acids and also interact with negatively charged carbohydrates at the cell surface, particularly GAGs that may play the same role PIP2 plays for secretion (31). Interaction with GAGs would help concentrate homeoproteins at the cell surface and trigger internalization, as first suggested by early in vitro experiments demonstrating that homeodomain internalization is higher in neurons than in fibroblasts (5). Similar to most morphogens, homeoproteins do not travel far in vivo and signal to neighboring cells (34), although a counterexample is provided by the brain-wide distribution of OTX2 after secretion from the choroid plexus into the cerebrospinal fluid, where OTX2 is likely bound to a carrier (46, 50). Cortical distribution of OTX2 also highlights another role of homeoprotein-GAG interaction, as OTX2 specifically accumulates in cortical PV cells thanks to high-affinity binding to GAGs within their PNNs (31). The GAG-binding motif in OTX2 overlaps with the first helix of the homeodomain, and similar sequences are present in several homeoproteins (6), suggesting the existence of a sugar code for homeoprotein-cell recognition that guides transfer specificity and noncell-autonomous activity.

The capacity of a large number of homeoproteins to transfer is less of an open question despite the initial focus on only few homeoproteins. Noncell-autonomous in vivo activity has been reported for EN1/2, PAX6, OTX2, KN1, several HOXs, and VAX1 (10, 27, 34, 35, 45, 6570), while all in vitro studies addressing the cellular mechanisms of transfer were done mainly with EN2. The hypothesis that most homeoproteins transfer in vivo is now supported by systematic assays involving 160 diverse homeoproteins in which intracellular transfer was confirmed for more than 150 homeoproteins both in HeLa cells and in mouse embryonic brain (13). However, an important issue that remains less well understood is the regulation of secretion and internalization, which is likely distinct for each homeoprotein. As discussed above, regulation may be through nuclear import/export, phosphorylation, vesicular transport, binding to PIP2, and recognition by complex sugars. For internalization, specific target cell recognition is necessary when the protein is in the extracellular milieu, as in the case of OTX2. However, if homeoproteins are secreted in the vicinity of the target cells, then their very limited diffusion may ensure specificity, as seen in the optic tectum or wing epithelium. Last, as discussed above, homeoproteins may cosignal with other classical pathways, as shown for EN1/2 (27, 29, 34) and PAX6 (35). If so, the regulation of homeoprotein signal transduction must include that of the cosignaling classical pathways.

Last, an unexpected consequence of homeoprotein internalization is the possibility to use them as therapeutic proteins, as shown for OTX2 in a mouse model of glaucoma (71) and for EN1/2 in rodent and nonhuman primate models of Parkinsons disease (72, 73). A single injection of homeoprotein has long-lasting protective effects best explained, at least in the case of EN1/2, by an ability to restore heterochromatin marks and to fight genomic instability (74, 75).

Among the hypothetical functions of homeoprotein signaling, two are of interest in the context of evolution. How can homeoproteins be considered true morphogens under the terms proposed by Turing (76), and can homeoprotein signaling be considered the first sexual exchange during the mating of unicellular eukaryotes (77)?

In The Chemical Basis of Morphogenesis (76), Turing proposed that two morphogens in the presence of a catalyst allow for the creation of heterogeneities within an originally unified field. For this to happen, the two morphogens must have different diffusion constants and autoactivating properties and must be reciprocal inhibitors. During compartmentalization, two homeoproteins expressed on either side of a future boundary have the two latter properties while the first one (different diffusion constants) is not necessary as they are not uniformly distributed. Their initial graded distributions are under the control of classical morphogens, fitting different models derived from the French Flag one proposed by L. Wolpert (78). In the example shown in Fig. 4, two opposing gradients of EMX2 and PAX6 define the positioning of the visual and sensory areas in the developing mouse cortex at embryonic day 11 (79). Modifying the dosage equilibrium between the Emx2 and Pax6 pushes the boundary backward or forward (79, 80). This is also the case for several boundaries, such as the midbrain/hindbrain boundary defined by the OTX and GBX2 (81, 82), the pallium/subpallium boundary defined by GSH2 and PAX6 (83, 84), or the Zona Limitans Intrathalamica defined by OTX1/2 and IRX1 (85). In the latter reports, boundary positioning by opposing homeoproteins is entirely explained by their cell-autonomous activities. However, based on the demonstration of homeoprotein noncell-autonomous activity, including the role of extracellular PAX6 in the regulation of Cajal-Retzius cell migration in the developing mouse cortex (70), we speculate that homeoprotein diffusion may also participate in forming boundaries. Accordingly, a mathematical model shows that adding short-distance homeoprotein diffusion to the classical French Flag model allows for the formation of straight and stable boundaries (86). This displacement of boundaries by changes in the expression of abutting homeoproteins, be it cell autonomous or not, is of evolutionary importance, as it allows for changes affecting the volume of cortical and subcortical regions, not necessarily implying a modification of the global size of the brain, sometimes with behavioral consequences, as shown by the increased locomotor activity of mice with a shifted midbrain/hindbrain boundary (87).

(A) General principle of how local noncell-autonomous activities of two homeoproteins (HP1 and HP2) are proposed to participate in the positioning of boundaries. The autoactivation and reciprocal inhibition properties of HP1 and HP2 have the consequence that, for above a threshold in the difference of HP1 and HP2 concentration, the winner takes all and a stable boundary is formed (86). This reciprocal homeoprotein signaling is possibly in interaction with classical signaling. A change in HP1/HP2 ratio modifies the position of the boundary, without changing the entire surface of the morphogenic fields added together. (B) Illustration of how the general principle illustrated in (A) may apply to the positioning of V1 and somatosensory (S1) cerebral cortex territories. Pax6 and Emx2 present two opposite anterior (A)posterior (P) gradients of expression. The positioning of the S1/V1 boundary is modified by a change in Pax6 or Emx2 cell-autonomous gene dosage (80). WT, wild type.

Sex recognition in unicellular eukaryotes has been widely studied in Saccharomyces cerevisiae and in green algae Chlamydomonas reinhardtii, where mating types are defined by specific homeoproteins, such as Mat-alpha1 and Mat-alpha2 in Saccharomyces or GSM1 and GSP1 in Chlamydomonas (3, 88). Differences exist between the two species, but mating strategies have many points in common. Using C. reinhardtii as an example, this green algae proliferates as haploid mt+ (expressing GSP1) and mt (expressing GSM1) cells until food deprivation induces loss of cell wall followed by conjugation (89). Conjugation or haplotype fusion, triggered by adhesion molecules at the surface of flagella, allows for the formation of GSM1:GSP1 dimers that activate zygotic gene expression. The zygote remains dormant until food supply increases and meiotic divisions take place, yielding a new generation of dividing haploid cells. GSM1 and GSP1 belong to the Knotted and Bell family of homeoproteins, respectively, raising the possibility that they can transfer between gametes before fusion (63). Accordingly, de novo protein synthesis, which is required to maintain flagellar adhesion during gamete activation (90), would depend on GSM1 and/or GSP1 transfer before cell fusion (91, 92).

There is not a physiology for health and another for illness; most pathological states stem from derailed physiological processes. Thus, the discovery of novel physiological pathways can increase our understanding of some pathologies and lead to original therapeutic approaches. An example is the observed regulation of cerebral cortex plasticity through noncell-autonomous OTX2 activity. Reducing OTX2 transfer to PV cells reopens plasticity in adult mice and can cure them from experimental amblyopia (31, 46). Whether these findings represent a possible advance in our understanding of the etiology of psychiatric diseases is worth considering. As discussed above, cerebral cortex and subcortical nuclei evolution is a question not only of global size but also of changes in connectivity (93) and in the positioning of boundaries, with the relative increase of the anterior parts of the brain in relation to the posterior ones, particularly within the primate clade (94, 95). As such, one can anticipate commonalities in regulatory mechanisms among all cortical functions, including mood and cognition.

Commonalities suggest that critical period regulation in V1 is recapitulated in higher-order cortices. This hypothesis has received recent support from studies showing that maternal separation in mice between a 10-day critical period, from postnatal day 10 to postnatal day 20, can induce permanent anxiety and depressive phenotypes (96). In the non-resilient offspring, Otx2 expression is down-regulated in the ventral tegmental area (VTA) during maternal separation while anxiety can be reversed in the adult by viral Otx2 expression in the VTA, which demonstrates an important cell-autonomous role for OTX2 within the VTA. In a similar maternal separation paradigm, anxiety was accompanied by increased choroid plexus OTX2 expression and altered transfer in ventral hippocampus PV cells, which suggests a parallel noncell-autonomous role for OTX2 (97). In ocular dominance plasticity, antagonizing OTX2 synthesis in the retina during the critical period delays PV cell maturation in V1 (45). By drawing a parallel between the systems, we hypothesize that the VTA plays a similar role in activating cortical and subcortical regions involved in mood regulation, as the retina plays for activating V1 maturation (Fig. 5). In both cases, OTX2 regulates the maturation of the periphery (VTA and retina) through cell-autonomous activity and regulates the maturation of cortical PV cells noncell-autonomously to ensure the proper shift in excitatory/inhibitory balance in the corresponding cortex. Many psychiatric diseases may be routed in biological and/or environmental adversity experienced during critical periods. Schizophrenic patients show defective PNN maturation in the dorsolateral prefrontal cortex (98) and disrupted cortical inhibition, leading to reduced high-power oscillations (99). DNA samples from maltreated children reveal a correlation between depression and the methylation status of OTX2 and its downstream targets (100), strengthening the hypothesis that OTX2 is an important modulator of mental health.

For V1 ocular dominance critical period onset, visual activity stimulated by light (1; green box) coupled with OTX2 passage (2) is required to activate PV cell maturation (3), which initiates PNN assembly (green circle arrows) (45). OTX2 from cerebrospinal fluid (blue box) is captured by PNNs (4) and accelerates PV cell maturation and PNN assembly (14, 46). Dark rearing (1; red box) reduces V1 input and delays PV cell maturation and PNN assembly (red circle arrows). In behavioral paradigms, physiological signals (1; green box) [or, respectively, stress (1; red box)] increases (or, respectively, reduces) expression of Otx2 and its targets in the VTA (2) and choroid plexus (96, 97). It is hypothesized that this activation (or reduction) affects the activation of PV cell maturation (3 and 4; pink) in various limbic cortical structures. Green and red arrows show up- and down-regulation, respectively, of either neuronal activity, protein transduction, or gene expression.

Because homeoproteins are present in all eukaryotes, including unicellular eukaryotes (7), their signaling properties must be very ancient. Pursuing the idea that homeoproteins signal during unicellular eukaryote mating, one can propose that they are at the origin of organ diversification in the first multicellular organisms. In this context, if we adopt the idea that multicellular organisms do not derive from cleavages taking place in multinucleated cells but from the aggregation of individual cells followed by compartment specialization (101), then slime molds provide an interesting model. Dictyostelium aggregation is promoted upon starvation by cAMP (cyclic adenosine monophosphate) signaling, and the aggregates produce a slug with three main anteroposterior domains: prestalk A (pstA) cells, prestalk O (pstO) cells, and anterior-like cells (ALCs), which represent 10, 10, and 80% of the body, respectively (102). pstO and ALC cells are in equilibrium and form a boundary that can be shifted to the advantage of the pstO compartment by knocking out DdHbx-2, a homeobox gene expressed only in the ALC and pstA compartments, very similarly (Fig. 4) to what was proposed for boundary positioning in the developing brain with homeoproteins behaving like Turing morphogens (76).

Homeobox genes are expressed by all eukaryotic cells, which makes it likely that they were also expressed earlier in the progeny of the Last Universal Common Ancestor. This means that homeoprotein signaling may have preceded all classical types of signaling, which is consistent with secretion and internalization, requiring no specific apparatus or receptors. Hence, homeoproteins may have been very primitive signaling entities, getting across the plasma membranes to noncell-autonomously regulate translation, transcription, or epigenetic marks. If so, other signaling mechanisms based on agonist-receptor interactions would have been later selected for their ability to add robustness to homeoprotein signaling. Homeoproteins cosignal with classical signaling molecules, as shown for EN1/2 and Ephrin in axon guidance (27), PAX6 and Netrin for oligodendrocyte precursor migration (35), and Engrailed and DPP in the fly anterior cross vein formation (34).

While there are clearly established functions associated with direct noncell-autonomous homeoprotein activity (Table 1), we have described only a few of them and, in a more speculative mood, proposed others that remain hypothetical. Considering that there are more than 250 homeoproteins, as compared to the 23 members of the FGF family (103), for example, our present knowledge might be the tip of the iceberg. If all homeoproteins that can transfer actually do so with physiological relevance, then homeoprotein transfer might represent, at least quantitatively, the most common mode of signal transduction.

Acknowledgments: We would like to thank F. Maloumian for assistance with figure illustrations. Funding: Funding was provided by the European Research Council (ERC-2013-ADG-339379 to A.P.) and the Agence Nationale de la Recherche (ANR-18-CE16-0013-01 to A.P. and A.A.D. and ANR-17-CE11-0050 to A.J.). Author contributions: A.A.D., A.J., and A.P. wrote the manuscript. Competing interests: A.P. is cofounder of BrainEver for development of homeoprotein-based therapeutics. The other authors declare that they have no competing interests.

Go here to read the rest:
Homeoprotein transduction in neurodevelopment and physiopathology - Science Advances

PhDs, peas and cricket teas; Dr Kevin Pyke’s alumni story – The John Innes Centre

Dr Kevin Pyke completed his PhD on leafless and semi-leafless peas, here at the John Innes Centre in the 1980s.

We recently caught up with Kevin, to talk peas, PhDs, four-colour graphs and the John Innes Cricket team.

I started at John Innes on the same day that HaroldWoolhousebecame Director, back in October 1980. I had arrived to work with Cliff Hedley and Mike Ambrose in Applied Genetics on leafless and semi-leafless peas.

A year or so earlier I had speculatively written eight letters around the country asking about PhDs including one to John Innes where my friend, Peter Lumsden had just done a summer placement.

I been interested in nature from an early age and it was my major interest through my childhood both in growing vegetables, collecting cacti and bird watching and general nature studies.It was clear that I was going to have a life involving biology in some way

I was the only child in my class at primary school to pass the 11-plus in 1969, finding myself atHuishs Grammar school for boys in Taunton where the education was excellent. Being passionate about the subject,I excelled in the sciences, especially biology and chemistry.

At that time Undergraduate sandwich courses were very popular where one did placements in research institutes and industry, giving awell-roundedappreciation of how research and development operates.

Thus,I did the Degree in Applied Biology at the University of Bath starting in 1976.

It was afour-yeardegree, the first two years being general biology and the third and fourth years having a choice of specialisations either animal science, crop science, microbiology or plant science.It was clear that I was bound to choose plant scienceand looking back on this I was very lucky as today no such opportunity exists to get that much experience.

On joining the John Innes, I recall there was quite a gulf though between those doing the new fast developing field of molecular biology and the rest of which I was a part.

I also vividly remember how friendly the people were. I quickly made friends with lots of PhD students, in particular PaulLazzeriwho started his PhD on tissue culture the same day as me with Graham Hussey.

A year later Anil Day started his PhD with Noel Ellis and we became friends. I was greatly inspired by Noel and that led to us doing a Southern blot experiment on rogue pea plastid DNA in late 1983 which made it as a chapter in my thesis.

Other memorable people from those times who I got to know well were Trevor Wang, BrianSnoadand Rod Casey.

The thing I remember most about the social side was the John Innes cricket team of which I was a main member during my time. The main organiser of the team and captain was PaulLinsteadfrom Cell Biology (affectionately known as sleepy hollow in those days).

In the summer we played on the UEA cricket pitches weekly in friendlies against local cricket teams from Norwich and surrounding villages as well as playing away matches.

I was a spin bowler and took lots of wickets and in my last year was captain. This was tremendous fun and there were several memorable people in the team in those days including JimDunwell, who opened the batting, Anil Day andNormanSunderlands son who was a young chap who was rather good and helped us out when we were short. On occasion the new Director HaroldWoolhouseused to wander across to watch sometimes and on a couple of occasions he umpired.

During my time at John Innes science evolved rapidly especially molecular biology and computing. I produced lots of data and wrote lots of papers so by the time I graduated I had my name on seven papers and conference proceedings.

I wrote all my thesis on the VAX main frame computer and Tam, D Roys secretary, typed it up on A4 pages for me costing 1 a page. Computing had just bought the first flat bed graph plotter and I printed out all the graphs in my thesis in four colours. At the time that was a major event.

They were wonderful times and I really enjoyed my PhD work looking at the plant physiology and crop physiology of the leafless and semi-leafless mutant phenotypes of pea.

From the John Innes I went on to doa post doc on leaves and chloroplasts with Professor Rachel Leech in York. I ultimately stayed therefor 11 years before getting a lectureship at Royal Holloway in 1994 andfinallymoving toa lectureship In Plant Sciences atNottingham in 1999.

I have worked at the Sutton Bonington campus ever since, researching chloroplasts, leaves and tomato plastids.Hopefully I have also inspired large number of students in the ways of plants and plant sciences over the years.

I took partial retirement in 2018 on turning 60 but I look back on my career in plants science with great affection,especiallymy time at the John Innes.

Thank you to BridgetGillies from the UEA Archives for the photo.

Go here to read the rest:
PhDs, peas and cricket teas; Dr Kevin Pyke's alumni story - The John Innes Centre

Technology versus talent the great shoe-volution – Daily Maverick

Brigid Kosgei of Kenya heads to the finish line to win with a women world record time of 02:14:04 in the 2019 Chicago Marathon in Chicago, Illinois, USA, 13 October 2019. EPA-EFE/TANNEN MAURY

First published in Daily Maverick 168

Marathon. Half-marathon, 15km, 10km, 5km on the road. One-hour run, 10,000m and 5,000m on the track. These are some of the world records that have fallen in the past two years. What they have in common is that their conquerors have worn one specific shoe. Never before has a sport so traditionally celebrated as a test of human performance been so overtaken by questions about technology.

If world record lists exist as a type of archaeological record for statisticians to examine, they will one day look at the period between 2017 and 2020 and conclude that a seismic event took place to change distance running, ushering in a new era. That event was the creation of super shoes.

In the beginning

It began in 2017, when Nike first put its weight behind the attempt to break the two-hour marathon barrier. A new shoe was part of that, but sceptics had seen and heard this before, and dismissed it as Nike trying to leverage the hype into selling more shoes.

Kenyan Eliud Kipchoge scared that two-hour barrier, appropriately on the Formula 1 motor racing circuit of Monza, thanks in part to a series of contrivances that included a bunch of pacemakers relaying in and out of the race to run in a V-formation to shelter him from the wind, a pancake-flat course with no sharp turns to slow him down, and fluids hand-delivered to bypass the inconvenience of veering off course or slowing down to drink. But it was the shoe that would soon emerge as the real star of the show.

First came the promised research. For once, a marketing claim about performance-enhancing shoes proved to have some substance behind it. At the time of its introduction, the shoe was said to have been called the 4% because laboratory studies had found that it improved something called running economy by that amount.

Running economy is the athletes equivalent of fuel economy in a car it is the amount of oxygen used by the athlete to run one kilometre, and what exceptional distance runners have in common is that theyre all extremely economical. That, allied to a high VO2max (the maximum amount of oxygen a person can utilise during intense exercise) and a lactate threshold (think cruising capacity) are the key elements for the worlds greatest marathon runners.

A research study confirmed that what Nike had figured out was a way to reduce the cost of running at a given speed. Through a combination of a new foam material and a curved carbon-fibre plate, a runner could now achieve the same pace, but use less oxygen.

And by extension, the runner would be able to run faster before bumping up against the physiological ceilings that normally exist because of oxygen supply to the muscles. The 4% running economy advantage does not necessarily create a 4% performance advantage, but the estimate, based on laboratory research models, is for an improvement of 2% to 3%, or two to three minutes in a marathon. It would be like running slightly downhill when everyone else is on a flat road. Or like running with a pair of shoes that weighs only 100g when everyone else is weighed down by 400g shoes.

Game changer

Its an advantage that transformed distance running, contributing to what has in effect been a recalibration of running performances. First it emerged that the 2016 Olympic podiums were owned by the shoe, despite it not being commercially available at that time.

The mens marathon world record went to Kipchoge in 2018. Both the mens and womens half-marathon records were broken. In 2018 and 2019, virtually every major city marathon was won by an athlete wearing the shoe, most in new course records. Many athletes whose sponsorship deals were with other brands painted over the shoe upper to hide their disloyalty to their brands, just to have a chance at success.

Then the sub-two-hour barrier did fall to Kipchoge, in Vienna in October 2019; by then he was powered by a prototype of the third iteration of the shoe, the Alphafly Next%. The original 4% shoe, striking for its midsole thickness, was now even taller, with a 39mm stack height providing the scaffolding for the carbon plate, the elastic energy return of the foam, and serving also to lengthen the leg to further enhance running economy and performance.

A day later, the womens marathon world record was toppled. Paula Radcliffes time, unbeaten for 16 years, was the last monument to a previous era; it was not edged but destroyed by Bridget Kosgei in the Chicago Marathon.

The same technology of foam and carbon-fibre plate found its way into the specialist spikes worn by athletes on the track, and 2020 has delivered the results a womens 5,000m world record, and mens world records over 5,000m and 10,000m. The reality was impossible to ignore running had been recalibrated.

The moral problem

That alone is problematic for a sport that relies heavily on times and history for its value. The value of a world record is that it represents a new horizon for human physiology and is celebrated as a barometer of progress.

Usually, that progress is understood to mean the runner. None would dispute that, over many generations, there is a progressive evolution of technology, knowledge and physiology, which makes it foolish to compare Jim Peters, the marathon champion in the 1950s, with Kipchoge and his peers.

However, the pace of this development was sudden. It happened within a generation, it was unprecedented in impact and it is completely independent of the athlete the same runner, two days apart, might produce performances belonging to different eras, thanks to a shoe. That bothered many people.

Even more concerning is whether the shoes undermine the integrity of the result. Its one thing for records to fall, and for times to be recalibrated such that a 2:05 marathon becomes routine rather than exceptional. At least if everyone had the same benefit, it would leave the fundamental premise of running intact. That premise is that the winner is the athlete whose physiology is superior on the day. Refined and optimised by training, running rewards physiology, and creates the perception of something relatively pure.

But super shoes challenge this premise, for two reasons. The first is that the shoes are not available to all. Initially, it was Nike that had the first-mover advantage. Other brands scrambled to make up lost ground, and most now have their own version, but theyve had to negotiate regulations, patent laws and access to material barriers, and there remains no guarantee that they have closed the gap.

A difference of even 2% caused by shoes would be larger than the typical physiological difference between the top 10 athletes in the world, the result being that if you randomised the allocation of shoes among those 10 athletes, you could completely change the result of a race.

It would be analogous to watching Rafael Nadal outplay Novak Djokovic in Paris, knowing that if they were made to swap tennis rackets after two sets, it would be Djokovic sweeping Nadal off the court. It is anathema to running that technology affects the result more than physiology, but that is the implication if a degree of between-brand parity cannot be restored.

Second, when an item of equipment has the capacity to make such large differences to performance, it will invariably do so in groups of high responders and low responders. The former will see very large benefits if the average advantage from the shoe is 2%, theirs may be 5%.

Others may see no benefit at all. This spread five percentage points in this hypothetical scenario is so large that it is, all by itself, decisive to a race outcome. No longer would the athlete breaking the tape be the best runner, physiologically and psychologically, but rather he or she would represent the best runner/shoe interaction.

Regulatory pushback

Faced with these dilemmas, authorities acted. Sort of. In January, World Athletics hit pause as it introduced regulations that would limit the thickness of the midsole and prevent the excessive, unregulated use of carbon-fibre plates. The controlling bodys upper limit for stack height, conveniently, is exactly the same as the height of the Nike shoes that have rewritten the record books since 2016, and provides enough room for a smart engineer to continue to innovate and explore ways to drive humans ever faster.

The regulations thus leave enough scope for the existing problems to persist, and potentially, for new problems to manifest. A more cautious approach would have been to imitate what swimmings governing body did in 2010, when it banned hi-tech swimsuits after a similar set of outrageous performance leaps and distorted outcomes affected that sport in 2008 and 2009. The policy effectively rewound technology to a point where swimming ability, rather than swimmer/tech interface, would determine the result. World Athletics had the same opportunity, as it could have reduced the maximum allowable thickness of shoes to considerably less than the 40mm currently in place.

It did not, and so the sport moves forward at a pace driven more by engineers integrating super springy foam with carbon-fibre plates than by muscles, hearts, lungs and brains. DM168

Dr Ross Tucker is a sports scientist.

See the original post here:
Technology versus talent the great shoe-volution - Daily Maverick

People’s bodies now run cooler than ‘normal’ even in the Bolivian Amazon – The Conversation US

Feeling under the weather? Chances are you or your doctor will grab a thermometer, take your temperature and hope for the familiar 98.6 degrees Fahrenheit (37 degrees Celsius) everyone recognizes as normal.

But what is normal and why does it matter? Despite the fixation on 98.6 F, clinicians recognize that there is no single universal normal body temperature for everyone at all times. Throughout the day, your body temperature can vary by as much as 1 F, at its lowest in the early morning and highest in the late afternoon. It changes when you are sick, goes up during and after exercise, varies across the menstrual cycle and varies between individuals. It also tends to decline with age.

In other words, body temperature is an indicator of whats going on within your body, like a metabolic thermostat.

An intriguing study from earlier this year found that normal body temperature is about 97.5 F in Americans at least those in Palo Alto, California, where the researchers took hundreds of thousands of temperature readings. That meant that in the U.S., normal body temperature has been dropping over the past 150 years. People run cooler today than they did two centuries ago.

The 98.6 F standard for normal body temperature was first established by the German physician Carl Wunderlich in 1867 after studying 25,000 people in Leipzig. But anecdotally, lower body temperatures in healthy adults have been widely reported. And a study in 2017 among 35,000 adults in the U.K. observed a lower average body temperature of 97.9 F.

What might cause these subtle but important changes? And are these provocative hints of changes in human physiology occurring only in urban, industrialized settings like the U.S. and U.K.?

One leading hypothesis is that thanks to improved hygiene, sanitation and medical treatment, people today experience fewer of the infections that would trigger higher body temperatures. In our study, we were able to test that idea directly in a unique setting: among Tsimane horticulturalist-foragers of the Bolivian Amazon.

The Tsimane live in a remote area with little access to modern amenities, and we know from firsthand experience that infections are common from the common cold to intestinal worms to tuberculosis. Having worked with the Tsimane studying a variety of topics related to health and aging for two decades, our team had a rich opportunity to observe whether body temperatures were similarly declining in this tropical environment where infections are common.

As part of our ongoing Tsimane Health and Life History Project, a mobile team of Bolivian physicians and researchers has been traveling from village to village monitoring health while treating patients. They record clinical diagnoses and lab measures of infection at each patient visit.

When we first started working in Bolivia back in 2002, Tsimane body temperatures were similar to what was found in Germany and the U.S. two centuries ago: averaging at 98.6 F. But over a relatively short period of 16 years, we observed a rapid decline in average body temperature in this population. The decline is steep: 0.09 F per year. Today Tsimane body temperatures are roughly 97.7 F.

In other words, in less than two decades were seeing about the same level of decline as that observed in the U.S. over approximately two centuries. We can say this with confidence, as our analysis is based on a large sample (about 18,000 observations of almost 5,500 adults), and we statistically control for multiple other factors that might affect body temperature, like ambient temperature and body mass.

More importantly, while having certain ailments, like respiratory or skin infections, was associated with higher body temperature during a medical visit, adjusting for these infections did not account for the steep decline in body temperature over time.

So why have body temperatures decreased over time, both for Americans and Tsimane? Fortunately, we had data available from our long-term research in Bolivia to address some possibilities.

For example, declines might be due to the rise of modern health care and lower rates of lingering mild infections now compared to in the past. But while it may be the case that health has generally improved in Bolivia over the past two decades, infections are still widespread among the Tsimane. Our results suggest that reduced incidence of infection alone cant explain the observed body temperature declines.

It could be that people are in better condition, and so their bodies dont need to work as hard to fight infection. Or more access to antibiotics and other treatments means that duration of infection is lower now than in the past. Its also possible that greater use of certain medications like ibuprofen or aspirin may reduce inflammation and be reflected in the lower temperatures. However, while lab measures of system-wide inflammation were associated with higher body temperature during patient visits, accounting for this in our analyses did not affect our estimate of the amount that body temperature declined per year.

Another possible explanation for the historical declines in body temperature is that bodies now dont need to work as much to regulate internal body temperature because of air conditioners in the summer and heaters in the winter. While Tsimane body temperatures do change with the time of year and weather patterns, the Tsimane dont use any advanced technology to regulate their body temperature. They do, however, have more access to clothes and blankets than they previously did.

[Deep knowledge, daily. Sign up for The Conversations newsletter.]

Understanding why body temperatures are declining remains an open question for scientists to explore. Whatever the reason, though, we can confirm that body temperatures are below 98.6 F outside of places like the U.S. and U.K. even in rural and tropical areas with minimal public health infrastructure, where infections are still the major killers.

We hope that our findings inspire more studies about how improved conditions might lower body temperature. As its fast and easy to measure, body temperature might one day prove to be a simple but useful indicator, like life expectancy, that provides new insight into population health.

Excerpt from:
People's bodies now run cooler than 'normal' even in the Bolivian Amazon - The Conversation US